期刊文献+

血小板衍生生长因子促进肝星状细胞活化在肝癌肿瘤微环境中的作用 被引量:1

Effect of platelet derived growth factor on inducing hepatic stellate cell activation in tumor microenvironment of hepatocellular carcinoma
原文传递
导出
摘要 肝星状细胞(HSC)在肝纤维化中的作用已被公认,近年来HSC在肝脏肿瘤微环境中的作用也逐渐引起人们重视.血小板衍生生长因子(PDGF)是HSC最重要的有丝分裂原,其在HSC的活化中具有极为重要的作用.HSC既是PDGF的作用靶细胞,同时也可分泌PDGF,从而形成PDGF激活HSC的双向循环模式.PDGF可通过MAPK、PI-3K、Ca2+、JAK等信号通路激活HSC.研究PDGF激活HSC在肝脏肿瘤微环境中的作用机制,寻找靶向抑制PDGF及肝星状细胞的相应方法,有望为肝脏肿瘤的治疗提供新的方向. The function of hepatic stellate cell (HSC)in liver fibrosis has been well recognized.In recent years,the role of HSC in the liver tumor microenvironment have been paid increasing attention.Platelet derived growth factor (PDGF) is the most important mitogen of hepatic stellate cell,and plays an important role in the activation of hepatic stellate cell.Hepatic stellate cell is not only the target cells of PDGF,but also PDGF-secreting cells.Thus a bi-directional cycle mode of PDGF activating hepatic stellate cell has been established.The signaling pathways of HSC activation include MAPK,PI-3K,Ca2+ and JAK pathways.To explore PDGF activating hepatic stellate cell in liver tumor microenvironment and to find the new methods of targeting PDGF and hepatic stellate cell,may help us find a new direction for the treatment of hepatocellular carcinoma.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2014年第12期905-909,共5页 Chinese Journal of Hepatobiliary Surgery
基金 国家自然科学基金(30971340)
关键词 肝星状细胞 血小板衍生生长因子 肝癌 肿瘤微环境 Hepatic stellate cell Platelet derived growth factor Hepatocellular carcinoma Tumor microenvironment
  • 相关文献

参考文献33

  • 1Soon RK Jr, Yee HF Jr. Stellate cell contraction: role, regulation, and potential therapeutic target [J]. Clin Liver Dis, 2008,12(4):791-803.
  • 2Bai Q, An J, Wu X, et al. HBV promotes the proliferation of hepatic stellate cell via the PDGF-B/PDGFR-β signaling pathway in vitro [J]. Int J of Mol Med, 2012,30(6):1443-1450.
  • 3Kwiecinski M, Elfimova N, Noetel A, et al. Expression of platelet-derived growth factor-Cand insulin-like growth factor I in hepatic stellate cell is inhibited by miR-29 [J]. Lab Invest, 2012,92(7):978-987.
  • 4Reigstad LJ, Varhaug JE, Lillehaug JR. Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family [J]. FEBS J, 2005, 272(22):5723-5741.
  • 5Borkham-Kamphorst E, van Roeyen CR, Ostendorf T, et al. Pro-fibrogenic potential of PDGF-D in liver fibrosis [J]. J Hepatol, 2007,46(6):1064-1074.
  • 6Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet-derived growth factor and its involvement in disease [J]. Mayo Clin Proc, 2006,81(9):1241-1257.
  • 7Cao R, Brakenhielm E, Li X, et al. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and-alphabeta receptors[J]. FASEB J, 2002,16(12):1575-1583.
  • 8Borkham Kamphorst E, Kovalenko E, van Roeyen CR, et al. Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury [J]. Lab Invest, 2008,88(10):1090-1100.
  • 9Thoen LF, Guimares EL, Grunsven LA. Autophagy-a new player in hepatic stellate cell activation [J]. Autophagy, 2012,8(1):126-128.
  • 10Senoo H. Structure and function of hepatic stellate cell[J]. Med Electron Microsc, 2004,37(1):3-15.

二级参考文献48

  • 1罗海峰,吴志勇,陈炜,邱江锋,张志奇,孟方斌.Smad2特异性siRNA对大鼠抗肝纤维化的作用[J].上海第二医科大学学报,2005,25(3):256-259. 被引量:3
  • 2曾军,杨镇.肝星状细胞、相关因子与肝纤维化关系的研究进展[J].中华肝胆外科杂志,2005,11(6):427-429. 被引量:8
  • 3朱跃科,王宝恩,申凤俊,贾继东,马红.实验性肝纤维化基质金属蛋白酶-2基因表达与酶活性的变化[J].中华肝脏病杂志,2005,13(7):509-512. 被引量:23
  • 4Kim R,Emi M,Arihiro K et al.Chemosensitization by STI571 targeting the platelet derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.Cancer,2005,103(9):1800.
  • 5Mukaratirwa S,Koninkx JF,Gruys E et al.Mutual paracrine effects of colorectal tumour cells and stromal cells:modulation of tumour and stromal cell differentiation and extracellular matrix component production in culture.Int J Exp Pathol,2005,86(4):219.
  • 6Jechlinger M,Sommer A,Moriggl R et al.Autocrine PDGFR signaling promotes mammary cancer metastasis.J Clin Invest,2006,116(6):1561.
  • 7Yang JD, Nakamura I, Roberts LR. The tumor microenviron- ment in hepatocellular carcinoma: current status and therapeu- tic targets[J]. Seminars in Cancer Biology, 2011,21:35-43.
  • 8Wilhelm SM, Adnane L, Newell P, et al. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling[J]. Mol Cancer Ther, 2008,7 : 3129-3140.
  • 9Lee JS, Semela D, Iredale J, et al. Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte? [J]. Hepatology, 2007,45 817-825.
  • 10Martinelli E, Troiani T, Morgillo F, et al. Synergistic antitu mor activity of sorafenib in combination with epidermal growth factor receptor inhibltors in colorectal and lung cancer cells[J]. Clin Cancer Res, 2010,16: 4990-5001.

共引文献4

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部